Navigation Links
Receiving chemotherapy after a breast cancer diagnosis may affect a patient's employment
Date:4/27/2014

A new study has found that loss of paid employment after a diagnosis of early-stage breast cancer may be common and potentially related to the type of treatment patients received. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings support efforts to reduce the side effects and burden of treatments for breast cancer and to identify patients who may forego certain treatments, particularly when the expected benefit is low.

Many women with early-stage breast cancer are working at the time of diagnosis and survive without cancer recurrence. Therefore, it's important to understand the impacts of chemotherapy on early-stage breast cancer survivors' employment. Reshma Jagsi, MD, of the University of Michigan Health System, and her colleagues studied 2290 women in the Los Angeles and Detroit areas who were diagnosed with nonmetastatic breast cancer between 2005 and 2007 and who completed surveys soon after diagnosis; 1536 of the women also completed a four-year follow-up questionnaire.

Of the 1026 patients under age 65 at diagnosis whose breast cancer did not recur and who responded to both surveys, 746 (76 percent) worked for pay before diagnosis. Of these, 236 (30 percent) were no longer working at follow-up. Women who received chemotherapy as part of initial treatment were less likely to be working at the four-year follow-up than women who were not treated with chemotherapy (38 percent vs 27 percent). Calculations showed that women who received chemotherapy at the time of diagnosis were 1.4-times more likely to be subsequently unemployed. Many women who were not employed after treatment wanted to work: 50 percent reported that it was important for them to work and 31 percent were actively seeking work.

"Many clinicians believe that although patients may miss work during treatment, they will 'bounce back' in the longer term. The results of this study suggest otherwise and highlight a possible long-term adverse consequence to adjuvant chemotherapy that may not have been fully appreciated to date," said Dr. Jagsi. She stressed the need to continue to develop strategies to identify patients who receive little benefit from chemotherapy and might be able to avoid it. "We also need to ensure that patients who are deciding on whether to receive chemotherapy understand the potential long-term consequences of receiving treatment, including possible implications for their employment and financial outcomes," she said.


'/>"/>

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
Wiley
Source:Eurekalert

Related medicine news :

1. Parents receiving heart disease diagnosis for infants need better information
2. More women receiving breast reconstruction after mastectomy, study finds
3. Patients receiving ADT should be counseled to improve mental and emotional well-being
4. Cine Learning's Online Story-based Leadership Courses Receiving Rave Reviews
5. US citizenship increases womens odds of receiving mammograms, cancer tests
6. Mayo-led study: Drug fails to reduce diarrhea in patients receiving radiation therapy
7. Swallowing exercises preserve function in head and neck cancer patients receiving radiation
8. Older Americans Not Receiving the Oral Health Care They Need
9. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offer Newly Designed hCG Diet Plans that Aid Patients in Receiving Improved Medical Care
10. Febe, a Scleroderma Patient, Starts New Life After Receiving a Stem Cell Treatment at World Stem Cells Clinic in Cancun
11. Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... Tribble Insurance Agency, a family owned and operated firm offering ... charity event to honor Chad Phillip Dermyer, a local police trooper who was shot ... and his fellow officers were conducting routine stops of suspects when one of them, ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second consecutive year, ... Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, ... been chosen by their peers for the 2017 list based on their exceptional ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales ... market. , Over the past 20 years SFI has been recognized as the world’s ... six new clients into the US market. The new clients include: Panacea Pro, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known ... Few people know that popular cosmetic fillers can enhance earlobes and ... medical director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... of Bioengineering are collaborating on a research project focused on multiple sclerosis (MS). ... seeks to use nanotechnology to control the disease without compromising normal immune function ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  Magnetic Insight Inc., leader in magnetic ... agreement with inviCRO LLC to develop intuitive image ... based on inviCRO,s VivoQuant™ visualization and post processing ... complete MPI solution package with the Momentum MPI ... imaging in vivo. MPI is a ...
(Date:1/18/2017)... 18, 2017  EnteroMedics Inc. (NASDAQ: ... neuroblocking technology to treat obesity, metabolic diseases and ... an underwritten public offering of units for gross ... discounts and commissions and offering expenses payable by ... Class A Units, priced at a public offering ...
Breaking Medicine Technology: